Objective: To examine the supply and status of fat-soluble vitamins in very low birth weight (VLBW) infants compared to a reference group of normal birth weight (NBW) infants. Design: A longitudinal study of VLBW infants in the early neonatal period. Blood samples were drawn at 1 week of age and at discharge from hospital. Plasma was analyzed for the fat-soluble vitamins: retinol, 25-OH-vitamin D, a-tocopherol and phylloquinone (vitamin K 1 ) using high-performance liquid chromatography. Subjects: A total of 40 VLBW infants were included in the study. A reference group of 33 NBW infants was randomly selected from one of our previous studies. Results: The VLBW infants received fortified human milk, and daily oral vitamin supplement (Multibionta). In VLBW infants, plasma retinol concentrations decreased and plasma 25-OH-vitamin D increased during the study period. VLBW infants had significantly lower plasma retinol (0.3 vs 0.7 mM) and higher plasma 25-OH-vitamin D (166 vs 25 nM) at discharge compared to NBW infants. Plasma phylloquinone concentration in VLBW infants was very high (53 ng/ml) at one week of age, especially in the youngest infants (192 ng/ml), but decreased rapidly during the study period resulting in low/normal plasma concentrations (0.9 ng/ml) at discharge. Conclusions: We observed alterations in plasma concentration of retinol and 25-OH-vitamin D in VLBW infants in the early neonatal period, resulting in marked differences between VLBW at discharge and NBW. Further trials are needed to evaluate whether changes in vitamin supplementation may improve clinical outcome in VLBW infants.
Introduction
Deficiency of fat-soluble vitamins may lead to serious health problems during fetal development as well as after birth.
Metabolites of fat-soluble vitamins are important ligands for several transcription factors. Retinoic acid is necessary for regulation of cell proliferation and differentiation. Deficiency of vitamin A may promote chronic lung disease, and increased susceptibility to infections and xerophthalmia (Shenai, 1999) . Vitamin D has important functions in calcium-and bone homeostasis and deficiency may lead to impaired bone mineralization and eventually rickets, in addition to altered immune responses (Shils, 1999) . Vitamin E acts as an antioxidant, and deficiency may cause hemolytic anemia and adversely affect development of the central nervous system in preterm infants (Azzi and Stocker, 2000; Brion et al., 2003) . Vitamin K is necessary for carboxylation of proteins that are important in blood coagulation and bone formation, and deficiency may cause neonatal hemorrhage (Saxena et al., 2001 ).
Compared to healthy newborns, premature infants have low plasma concentration of retinol, 25-hydroxyvitamin D and vitamin E at birth, reflecting that fetal accumulation of these vitamins mainly takes place in the last trimester of pregnancy (Haga and Lunde, 1978; Shenai et al., 1981; Baydas et al., 2002) . Plasma vitamin K levels are low at birth in very low birth weight (VLBW ¼ birth weight o1500 g) as well as normal birth weight (NBW ¼ birth weight 42500 g) infants (Greer et al., 1988; Kumar et al., 2001) . Human milk is the preferred nutritional source in enteral feeding of preterm infants (American Academy of Pediatrics, 1998) . However, the concentration of fat-soluble vitamins in human milk is low, compared to the recommended intake, and VLBW infants need supplementation (Greer, 2001) . Prophylactic vitamin supplementation is common, but the dosage and route of administration vary markedly (American Academy of Pediatrics, 1998; Shaw and Lawson, 2001; Hey, 2003) . Most studies of fat-soluble vitamins have been conducted in formula-fed infants. Little is known about the status of fat-soluble vitamins among breast-fed premature infants. Delvin et al. (2005) reported that oral vitamin supplementation resulted in similar plasma concentrations of these vitamins in breast and formula-fed infants (gestational age 33.5 weeks). The present study is the first to describe intakes and plasma concentrations for all four fat-soluble vitamins in VLBW infants (gestational age 29 weeks), compared to a reference group of NBW infants. Owing to sensitive and advanced high-performance liquid chromatography (HPLC) we have been able to monitor all the fat-soluble vitamins in plasma samples from even the smallest infants.
Methods

Patients
Fifty subsequent VLBW (birth weight o1500 g) infants born between April and October 2002 at Rikshospitalet University Hospital, Buskerud Hospital and Vestfold Hospital in Norway, were eligible for the study. Infants with major congenital abnormalities were not included, and those who developed cerebral hemorrhage (grade 3 or 4) as determined by ultrasound, were excluded from the study. Written informed consent was obtained from the parents and the study was approved by the Regional Ethics Committee. A reference group of 33 NBW (birth weight 42500 g, gestational age 437 weeks) infants at 4 weeks of age was randomly selected from one of our previous studies. The mothers of the NBW infants received vitamin-supplemented oil (1.2 mg vitamin A, 10 mg vitamin D and 14 mg vitamin E per day) from week 18 during pregnancy until 3 months after delivery, in accordance with current Norwegian recommendations (Helland et al., 2003) .
Dietary intake
Dietary intake of VLBW infants during the neonatal period was estimated from parenteral nutrition, human milk, formulas and oral supplements. The vitamin contents of commercially available products were obtained from the manufacturers. Vitamin intake from human milk was calculated using the Norwegian food composition table, and other sources (Bolisetty et al., 1998) . All VLBW infants were given 0.5 mg (i.m.) vitamin K 1 within 2 h after birth. Minimal enteral feeding with human milk was started as soon as possible, and the amount of parenteral feeding was reduced as the intake of human milk gradually increased. When the infants achieved an enteral intake of 100 ml/kg, the human milk was fortified with proteins and minerals (Presemp s Semper AB, Stockholm, Sweden). All VLBW infants received oral vitamin supplement (Multibionta Trophen Merck, Darmstadt, Germany) containing 12.5 mg of vitamin D, 750 mg of vitamin A (retinylpalmitate) and 2 mg of vitamin E (a-tocopherol). Infants on parenteral nutrition (n ¼ 10) received 1 ml/kg/day of Vitalipid (Vitalipid, Kabi Pharmacia) and 0.5 mg vitamin K 1 every third day. Most VLBW infants (n ¼ 27) received one additional daily dose of 15 mg vitamin E from birth to 32 weeks of gestational age. At discharge, 60% of the VLBW infant was breast-fed, and the remaining changed from donor human milk to term formula the last week before discharge.
All NBW infants were breast-fed during the study period. Apart from 1.0 mg (i.m.) vitamin K 1 at birth, NBW infants received no vitamin supplement during the first 4 weeks of life.
Blood sampling and analyses Blood samples (1 ml) from the VLBW infants were obtained in EDTA containers at 1 week of age and at discharge from the hospital. Blood samples were obtained from the NBW infants, at 4 weeks of age.
The blood samples were centrifuged, and plasma was stored at À801C until further analyses. The plasma concentration of retinol was used as an indicator of vitamin A status, and 25-OH-vitamin D was used as a marker of vitamin D status. We also determined the major form of vitamin E (atocopherol) and vitamin K 1 (phylloquinone). The analyses were performed with HPLC on a Hewlett Packard 1100 liquid chromatograph (Agilent Technologies, Palo Alta, CA, USA) with very high sensitivity. For detection of retinol, the method is linear at 0.1-10 mM and the lower limit of detection is 10 nM. The intra-assay coefficient of variation (CV) is 4.9-5.8%, using known standards during our analyses. For 25-OH-vitamin D, the method is linear at 5-400 nM and the lower limit of detection is 1-4 nM. CV is 5.2-5.8%. For tocopherol, the method is linear at 1-200 mM and the lower limit of detection is 10 nM. CV is 4.6-4.8%. For phylloquinone, the method is linear at 0.05-4 ng/ml, and the lower limit of detection was 0.01 ng/ml CV is 7.8-10%. 
Results
Patient characteristics
Fifty VLBW infants were initially eligible to participate in the study. Seven infants were not included due to lack of parental consent (n ¼ 2), transfer to another hospital (n ¼ 3), neonatal death (n ¼ 1) or early discharge (n ¼ 1). Two infants were excluded due to serious cerebral hemorrhage and one withdrew during the study. Thus, 40 infants participated in the study. Blood samples at 1 week of age were not taken if the infant had received blood transfusion (n ¼ 6). Blood samples were obtained from 32 (80%) of the infants one week after birth and from 26 (65%) infants at discharge. The median post-conceptional age at discharge was 37 weeks (35-40). There were no statistical differences in maternal age, birth weight or gestational age between participants and non-participants in the VLBW group (data not shown). The mothers in the NBW group had longer education and smoked less than the mothers in the VLBW group (Table 1) . Among the mother in the VLBW group, 21% reported daily smoking, 18% smoked from time to time and 61% were non-smokers.
Intake and plasma concentration of fat-soluble vitamins Vitamin A: The main source of vitamin A in VLBW infants was supplements, and the total vitamin A intake increased steadily during the study period (Figure 1a) . Median plasma retinol concentration declined during the study period (P ¼ 0.04) in VLBW infants (Figure 1b) . Plasma retinol concentrations in VLBW infants at discharge were significantly lower than for NBW infants at 4 weeks of age (Table 2) .
Vitamin D: The main source of vitamin D in VLBW infants was supplements, and the total vitamin D intake increased steadily during the study period (Figure 2a) . Plasma 25-OHvitamin D concentration increased (Po0.001) in VLBW infants (Figure 2b ). At discharge VLBW infants had significantly higher concentration of 25-OH-vitamin D than NBWs at 4 weeks of age (Table 2) .
Vitamin E: The main source of vitamin E in VLBW infants was supplements, and the total intake declined after 32th gestational week (Figure 3a) . Plasma concentration of atocopherol decreased in VLBW infants during the study ( Figure 3b , Table 2 ). There was no significant difference between plasma concentration of a-tocopherol in VLBW at discharge and NBW infants at 4 weeks of age (Table 2) .
Vitamin K: The main source of vitamin K was from supplements, and the total intake declined during the study period (Figure 4a ). In infants who changed from donor milk Fat-soluble vitamins C Henriksen et al to formula, the intake of vitamin K increased prior to discharge. For infants receiving human milk, the intake of vitamin K remained low during the rest of the study period. Plasma concentration of phylloquinone was markedly elevated at 1 week of age (Figure 4b) , with considerable individual variation. VLBW infants born at gestational age o28 weeks had much higher plasma phylloquinone levels than infants with gestational age 428 weeks (191.5 vs 19.3 ng/ml, P ¼ 0.005) one week after birth. VLBW infants on parenteral nutrition had higher plasma concentrations of phylloquinone than infants on enteral nutrition at similar age (P ¼ 0.007). Plasma phylloquinone levels were low in both groups at discharge/4 weeks age (Table 2 ). All the NBW infants were breast-fed, but only 60% of the VLBW infants were breast-fed at discharge. However, VLBW infants had received mainly human milk during the study period, and there were no significant difference in plasma vitamins between breast-fed and non-breast-fed VLBW infants at discharge (data not shown).
Discussion
The most striking finding in our study was the changes in plasma concentration of retinol and 25-OH-vitamin D in VLBW infants in the neonatal period, resulting in marked differences between VLBW at discharge and NBW at 4 weeks of age.
The decline in plasma retinol concentration in VLBW infants may be of clinical importance because there is an association between retinol status and the risk for developing chronic lung disease (Hustead et al., 1984; Shenai et al., 1985; Chabra et al., 1994; Inder et al., 1998) . The optimal plasma retinol concentration for newborn infants is not known. Applying 0.7 mM plasma retinol as lower reference limit (de Pee and Dary, 2002) , all VLBW infants and 47% of the NBW infants were deficient at discharge and 4 weeks after birth, respectively. The observed intake of vitamin A in the VLBW group was 2-3 times higher than the NBW infants. The low plasma retinol levels at discharge might be explained by higher needs and/or impaired absorption in the VLBW group. The oral supplement contains retinylester, which has to be hydrolyzed prior to absorption (Harrison and Hussain, 2001) , and possibly the involved enzymes have reduced activity in VLBW infants. Low-fat intake and lack of bile salts may further reduce bioavailability (Shils, 1999) . This is in accordance with results showing that oral supplementation of 1500 mg retinol/day was inadequate for obtaining optimal serum retinol concentration in very preterm infants (Wardle et al., 2001) , and further supported by the observation that i.m. administration of vitamin A Fat-soluble vitamins C Henriksen et al normalizes serum retinol concentration, and decreases the risk of death, chronic lung disease and oxygen requirement in preterm infants (Darlow and Graham, 2002) . However, i.m. administration of vitamin A in very preterm infants is not generally accepted, and oral administration would be preferable. A rapid increase in plasma 25-OH-vitamin D was observed during the neonatal period, suggesting that a daily supplement of 12.5 mg may be too high. This is in contrast to previous studies (Markestad et al., 1984; Backstrom et al., 1999; Delvin et al., 2005) , although our study included smaller and more immature infants. Excessive intake of vitamin D may lead to hypercalcemia and calcification of soft tissues. Serum 25-OH-vitamin D concentration 4220 nM is associated with hypercalcemia in adults (Vieth, 1999) . Six infants (22%) in the present study had 25-OH-vitamin D levels 4220 nM at discharge, but no signs of hypercalcemia were observed. The recommended daily dose of vitamin D remains controversial and ranges between 4 and 25 mg/day (Committee on Nutrition of the Preterm Infant, 1987; American Academy of Pediatrics, 1998). Our results indicate that a supplement of 12.5 mg/day is too high. In NBW infants, the plasma concentration of 25-OH-vitamin D was low at 4 weeks of life. This is expected due to the low vitamin D concentration in human milk and lack of exposure to sunlight at our Northern latitude. Our observation is in accordance with the present Norwegian recommendations of vitamin D supplementation to breast-fed infants from 4 weeks of age.
Plasma a-tocopherol levels were within the reference range (14-50 mM) at discharge, except for two infants, who did not receive additional vitamin E supplement. The recommended daily dose of vitamin E varies between 6 and 12 mg/kg. Although controversial, very high (pharmacological) doses 
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C Henriksen et al of vitamin E have been proposed as an antioxidant to limit retinopathy, cerebral hemorrhage, hemolytic anemia and chronic lung disease with sepsis as a potential toxic side effect (Brion et al., 2003) . High-dose parenteral vitamin E supplementation or serum levels 480 mM are not recommended (Brion et al., 2003) . In the present study, four (13%) of VLBW infants in contrast to none of the NBW infants had a-tocopherol concentrations 480 mM. Plasma vitamin K 1 in VLBW was very high at 1 week of age compared to earlier studies in healthy newborns (Shearer et al., 1982; Greer et al., 1988) and in preterm infants (Kumar et al., 2001; Costakos et al., 2003) . Several authors, although not confirmed in randomized studies, have suggested deleterious side effects from high vitamin K levels such as childhood leukemia and hepatoblastoma (Roman et al., 2002) . At present, it is not known whether high plasma vitamin K concentration in the neonatal period increases disease risks. However, this uncertainty should enhance attention of vitamin K supplementation in VLBW infants.
Vitamin K 1 was low at discharge in breast-fed VLBW infants (0.7 ng/ml) as well as in NBW infants (0.3 ng/ml). Greer et al. (Greer, 1999) reported that plasma phylloquinone concentrations in infants fed human milk were low (o0.25 ng/ml) throughout the first 6 months of life compared to formula-fed infants (4.39-5.99 ng/ml). Reduced bone density is reported in preterm infants (Faerk et al., 2000) , and potentially low plasma vitamin K levels in breastfed, preterm infants may be a contributing factor (Weber, 2001) .
The VLBW and NBW infants differed in gestational age, birth weight, vitamin intake from supplements, and frequency of smoking during pregnancy among mothers. With our present design, we cannot separate the effect of prematurity from the effect of supplements. Smoking may also reduce the content of some vitamins in human milk, but most mothers quitted smoking during breastfeeding periods, and therefore can probably not explain the observed differences.
We compared VLBW infants at discharge to NBW infants. VLBW infants had higher chronological age (8 vs 4 weeks), but lower post-conceptional age (37 vs 44 weeks) compared to the NBW infants. Choice of sampling time is a general problem when comparing VLBW and NBW infants, and similarity of both chronological age and post-conception age are obviously not possible. The choice of sampling time has probably not affected our conclusions because most fatsoluble vitamins, except vitamin D, are stable in NBW infants in the early neonatal period.
In conclusion, the availability of very sensitive methods for measuring concentrations of fat-soluble vitamins has made it feasible to examine these vitamins in small plasma samples from preterm infants. VLBW infants had significantly lower plasma retinol and higher plasma 25-OHvitamin D levels at discharge as compared to NBW infants. There were no significant differences between plasma atocopherol levels in the two groups. Plasma phylloquinone levels in VLBW infants were extremely high at 1 week of age, especially in infants with gestational age below 28 weeks. However, plasma concentrations of phylloquinone levels were low in both groups at discharge/4 weeks of age. We suggest that plasma concentrations of fat-soluble vitamins should be monitored in VLBW infants to individually adjust supplementation. Further trials are needed to evaluate whether changes in vitamin supplementation may improve clinical outcome in VLBW infants. 
